相似文献
1
What makes Cryptococcus neoformans a pathogen?
Emerg Infect Dis. 1998 Jan-Mar;4(1):71-83. doi: 10.3201/eid0401.980109.
2
The tools for virulence of Cryptococcus neoformans.
Adv Appl Microbiol. 2014;87:1-41. doi: 10.1016/B978-0-12-800261-2.00001-3.
3
Virulence mechanisms and Cryptococcus neoformans pathogenesis.
Fungal Genet Biol. 2015 May;78:55-8. doi: 10.1016/j.fgb.2014.09.004. Epub 2014 Sep 23.
4
Elucidating the immunological function of the Cryptococcus neoformans capsule.
Future Microbiol. 2013 Sep;8(9):1107-16. doi: 10.2217/fmb.13.84.
5
Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans.
Fungal Genet Biol. 1998 Oct;25(1):1-14. doi: 10.1006/fgbi.1998.1079.
6
Cryptococcus neoformans: virulence and host defences.
Med Mycol. 1998;36 Suppl 1:79-86.
7
Transcriptomic and virulence factors analyses of Cryptococcus neoformans hypoxia response.
APMIS. 2017 Mar;125(3):236-248. doi: 10.1111/apm.12647.
8
[Physiopathology of meningoencephalitis caused by Cryptococcus neoformans].
Ann Med Interne (Paris). 2002 Sep;153(5):323-8.
9
Cryptococcus neoformans: a sugar-coated killer with designer genes.
FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):395-404. doi: 10.1016/j.femsim.2005.06.005.
10
Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection.
Am J Respir Cell Mol Biol. 2002 Mar;26(3):306-14. doi: 10.1165/ajrcmb.26.3.4479.
引用本文的文献
1
Polymorphic α-Glucans as Structural Scaffolds in Cryptococcus Cell Walls for Chitin, Capsule, and Melanin: Insights From C and H Solid-State NMR.
Angew Chem Int Ed Engl. 2025 Jul 8:e202510409. doi: 10.1002/anie.202510409.
2
Evidence for the role of Irk2 and Irk5 in ATP and metabolism regulation in .
Front Cell Infect Microbiol. 2025 Jun 18;15:1600041. doi: 10.3389/fcimb.2025.1600041. eCollection 2025.
3
An Optimized In-House Protocol for DNA Extraction from Whole Blood: "Comparison of Lysis Buffer and Ox-Bile Methods".
J Fungi (Basel). 2025 Jun 4;11(6):430. doi: 10.3390/jof11060430.
4
Involvement of CD146 in the adhesion and infection of brain endothelial cells.
Infect Immun. 2025 May 13;93(5):e0014525. doi: 10.1128/iai.00145-25. Epub 2025 Apr 10.
5
Integrative Proteome and Metabolomics Analyses of Cryptococcus neoformans Responses to Melanin Substrates Niger seed and L-DOPA.
Curr Microbiol. 2024 Nov 8;81(12):451. doi: 10.1007/s00284-024-03979-0.
6
Design of an epitope-based peptide vaccine against Cryptococcus neoformans.
FEBS Open Bio. 2024 Sep;14(9):1471-1489. doi: 10.1002/2211-5463.13858. Epub 2024 Jul 17.
7
Progress in the application of nanoparticles for the treatment of fungal infections: A review.
Mycology. 2023 Dec 8;15(1):1-16. doi: 10.1080/21501203.2023.2285764. eCollection 2024.
8
Non-self glycan structures as possible modulators of cancer progression: would polysaccharides from Cryptococcus spp. impact this phenomenon?
Braz J Microbiol. 2023 Jun;54(2):907-919. doi: 10.1007/s42770-023-00936-0. Epub 2023 Feb 25.
9
Comprehensive genome-scale metabolic model of the human pathogen : A platform for understanding pathogen metabolism and identifying new drug targets.
Front Bioinform. 2023 Jan 13;3:1121409. doi: 10.3389/fbinf.2023.1121409. eCollection 2023.
10
Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.
PLoS Negl Trop Dis. 2023 Jan 19;17(1):e0011068. doi: 10.1371/journal.pntd.0011068. eCollection 2023 Jan.
本文引用的文献
1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
An antigen for detection of hypersensitivity to Cryptococcus neoformans.
Proc Soc Exp Biol Med. 1961 Nov;108:498-501. doi: 10.3181/00379727-108-26977.
3
Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP.
Genes Dev. 1997 Dec 1;11(23):3206-17. doi: 10.1101/gad.11.23.3206.
4
Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
J Infect Dis. 1997 Feb;175(2):414-20. doi: 10.1093/infdis/175.2.414.
5
Calcineurin is required for virulence of Cryptococcus neoformans.
EMBO J. 1997 May 15;16(10):2576-89. doi: 10.1093/emboj/16.10.2576.
6
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.
Infect Immun. 1997 Jun;65(6):2454-6. doi: 10.1128/iai.65.6.2454-2456.1997.
7
Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
Infect Immun. 1997 May;65(5):1836-41. doi: 10.1128/iai.65.5.1836-1841.1997.
8
Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.
Infect Immun. 1997 May;65(5):1584-92. doi: 10.1128/iai.65.5.1584-1592.1997.
9
Cryptococcal polysaccharides bind to CD18 on human neutrophils.
Infect Immun. 1997 Feb;65(2):557-63. doi: 10.1128/iai.65.2.557-563.1997.
10
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans.
Infect Immun. 1997 Feb;65(2):405-11. doi: 10.1128/iai.65.2.405-411.1997.
Zotero 插件